These novel therapies , Retatrutide, represent a significant advancement in treating type 2 diabetes and potentially related disorders. These drugs are grouped as GLP-1 hormone stimulators, signifying they function to replicate the natural GLP-1 hormone , stimulating insulin release and reducing